Literature DB >> 14751902

Antiretroviral therapy in Africa.

Warren Stevens1, Steve Kaye, Tumani Corrah.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14751902      PMCID： PMC324462          DOI： 10.1136/bmj.328.7434.280

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.

Authors:  Christian Laurent; Ndella Diakhaté; Ndeye Fatou Ngom Gueye; Mame Awa Touré; Papa Salif Sow; Mame Awa Faye; Mandoumbé Gueye; Isabelle Lanièce; Coumba Touré Kane; Florian Liégeois; Laurence Vergne; Souleymane Mboup; Salif Badiane; Ibrahima Ndoye; Eric Delaporte
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

2.  Adherence is not a barrier to successful antiretroviral therapy in South Africa.

Authors:  Catherine Orrell; David R Bangsberg; Motasim Badri; Robin Wood
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

Review 3.  HIV viral load markers in clinical practice.

Authors:  M S Saag; M Holodniy; D R Kuritzkes; W A O'Brien; R Coombs; M E Poscher; D M Jacobsen; G M Shaw; D D Richman; P A Volberding
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

4.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

5.  Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Authors:  P Lorenzi; M Opravil; B Hirschel; J P Chave; H J Furrer; H Sax; T V Perneger; L Perrin; L Kaiser; S Yerly
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

6.  Antiretroviral-drug resistance among patients recently infected with HIV.

Authors:  Susan J Little; Sarah Holte; Jean-Pierre Routy; Eric S Daar; Marty Markowitz; Ann C Collier; Richard A Koup; John W Mellors; Elizabeth Connick; Brian Conway; Michael Kilby; Lei Wang; Jeannette M Whitcomb; Nicholas S Hellmann; Douglas D Richman
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 7.  Fitness of drug resistant HIV-1: methodology and clinical implications.

Authors:  Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Drug Resist Updat       Date:  2002-12       Impact factor: 18.500

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

Authors:  M Zwarenstein; J H Schoeman; C Vundule; C J Lombard; M Tatley
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

10.  High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Authors:  David R Bangsberg; Edwin D Charlebois; Robert M Grant; Mark Holodniy; Steven G Deeks; Sharon Perry; Kathleen Nugent Conroy; Richard Clark; David Guzman; Andrew Zolopa; Andrew Moss
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177
View more
  23 in total

1.  Access to antiretroviral treatment in Africa.

Authors:  Rene Loewenson; David McCoy
Journal:  BMJ       Date:  2004-01-31

Review 2.  Primary drug resistance in South Africa: data from 10 years of surveys.

Authors:  Justen Manasa; David Katzenstein; Sharon Cassol; Marie-Louise Newell; Tulio de Oliveira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

Review 3.  Barriers to better care for people with AIDS in developing countries.

Authors:  Andrew S Furber; Ian J Hodgson; Alice Desclaux; David S Mukasa
Journal:  BMJ       Date:  2004-11-27

Review 4.  Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.

Authors:  Anthony D Harries; Edwin Libamba; Erik J Schouten; Andrina Mwansambo; Felix M Salaniponi; Rex Mpazanje
Journal:  BMJ       Date:  2004-11-13

Review 5.  Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities.

Authors:  David McCoy; Mickey Chopra; Rene Loewenson; Jean-Marion Aitken; Thabale Ngulube; Adamson Muula; Sunanda Ray; Tendayi Kureyi; Petrida Ijumba; Mike Rowson
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

6.  The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda.

Authors:  J T Crane; A Kawuma; J H Oyugi; J T Byakika; A Moss; P Bourgois; D R Bangsberg
Journal:  AIDS Behav       Date:  2006-07

Review 7.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

8.  "If She is Drunk, I Don't Want Her to Take it": Partner Beliefs and Influence on Use of Alcohol and Antiretroviral Therapy in South African Couples.

Authors:  Amy A Conroy; Stacey A McKenna; Anna Leddy; Mallory O Johnson; Thulani Ngubane; Lynae A Darbes; Heidi van Rooyen
Journal:  AIDS Behav       Date:  2017-07

9.  Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Authors:  Norma C Ware; John Idoko; Sylvia Kaaya; Irene Andia Biraro; Monique A Wyatt; Oche Agbaji; Guerino Chalamilla; David R Bangsberg
Journal:  PLoS Med       Date:  2009-01-27       Impact factor: 11.069

10.  Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.

Authors:  Janneke H van Dijk; Catherine G Sutcliffe; Bornface Munsanje; Francis Hamangaba; Philip E Thuma; William J Moss
Journal:  BMC Infect Dis       Date:  2009-10-16       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.